OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
TSHA
Taysha Gene Therapies, Inc.
There isn't enough reported data to score TSHA yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
TSHA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
TSHA's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
TSHA PE Valuation
TSHA has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
TSHA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| -- | |
| Limited | |
| High |
Analysts expect TSHA's losses to grow, with revenue declining.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over TSHA on earnings quality, reporting a profit while its opponent remains loss making.
TSHA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.43 | -$0.10 |
| Q2 2026 | -$0.42 | -$0.08 |
| Q1 2026 | -$0.38 | -$0.04 |
| Q4 2025 | -$0.34 | +$0.02 |
| Q3 2025 | -$0.33 | -197% |
| Q2 2025 | -$0.34 | +$0.15 |
| Q1 2025 | -$0.34 | +$0.44 |
| Q4 2024 | -$0.36 | +$0.60 |
TSHA is still losing money, but far less than before: $0.43 per share over the past year, against $5.08 at its worst in early 2022.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over TSHA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
TSHA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $5.5M | +171% |
| Q2 2025 | $2M | +79% |
| Q1 2025 | $2.3M | -33% |
| Q4 2024 | $2M | -44% |
| Q3 2024 | $1.8M | -62% |
| Q2 2024 | $1.1M | -54% |
| Q1 2024 | $3.4M | -28% |
TSHA's revenue is shrinking: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -516% | +470 points |
| Q2 2025 | -1347% | +568 points |
| Q1 2025 | -931% | -217 points |
| Q4 2024 | -986% | -535 points |
| Q3 2024 | -1448% | -1106 points |
| Q2 2024 | -1915% | -939 points |
| Q1 2024 | -713% | -361 points |
| Q4 2023 | -451% | N/A |
TSHA's operating margin was −516% last quarter, up 932 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over TSHA on cash generation, producing positive trailing cash flow while its opponent burns cash.
TSHA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$33.4M | -$9.1M |
| Q1 2026 | -$40.9M | -$18.9M |
| Q4 2025 | -$27M | -$8.7M |
| Q3 2025 | -$24.3M | -$2.6M |
| Q1 2025 | -$22M | -$2.1M |
| Q4 2024 | -$18.3M | -$2.2M |
| Q3 2024 | -$21.7M | -$3.7M |
| Q2 2024 | -$21.7M | -$3M |
TSHA has burned cash in almost every quarter: −$142M over the past year, against −$86M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
TSHA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +10% | +37.1M shares |
| 1 year | +15% | +52.8M shares |
| 3 years | +532% | +342M shares |
| 5 years | +998% | +369M shares |
| Available history | +2577% | +391M shares |
TSHA has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
TSHA Net Leverage
TSHA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
TSHA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 23.3 | Neutral |
TSHA's weekly RSI is 41 (neutral) and its Stochastic is 23 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
TSHA PE vs Healthcare Sector
| Metric | TSHA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
TSHA has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over TSHA on trend strength, trading above more of its moving averages.
TSHA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.25 | 0.9% below |
| 20 week MA | $5.21 | 19% below |
| 50 week MA | $5.25 | 20% below |
| 100 week MA | $3.94 | 6.9% above |
| 200 week MA | $2.92 | 44% above |
TSHA has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over TSHA on returns for 2026, with the stronger performance.
TSHA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.5 | $27.2 | +11% |
| 2021 | $27.2 | $12.8 | -53% |
| 2022 | $12.8 | $2.08 | -84% |
| 2023 | $2.08 | $1.77 | -15% |
| 2024 | $1.77 | $1.75 | -1.1% |
| 2025 | $1.75 | $5.83 | +233% |
| 2026 YTD | $5.83 | $4.21 | -28% |
TSHA's yearly returns have swung widely, from +233% in 2025 to −84% in 2022. It's down 28% so far in 2026.